How Mabion Builds Space for Women in Biopharma
- Women in biopharma at Mabion are empowered to grow beyond traditional boundaries. Our organizational culture is based on well-thought-out development plans. We treat every employee as a talent, encouraging them to develop, lead, and shape the biologics market.
- Scientific excellence is strengthened through collaboration, international exposure, and cross-functional engagement.
- At Mabion Biologics CDMO, development is not limited to biotherapeutics. It also concerns people and how scientific careers are nurtured, developed, and redefined.
From Manufacturing Floor to Business: Klaudia’s Expansion Beyond the Lab
When Klaudia Lechowska speaks about her career, there is no trace of accidental progression. There is intention in every step. Her recent interview for PharmTech, published for International Women and Girls in Science Day, is not simply a personal profile. It is a portrait of evolution.1
Klaudia began her journey in manufacturing, immersed in upstream bioprocessing operations. As a bioprocess technician, she worked hands-on with cell culture learning how biologics are produced, and what responsibility feels like when quality cannot be compromised. In those early years, she learned the language of biologics not from presentations, but from production reality. She understood what it means to scale from laboratory conditions to bioreactors.
But Klaudia’s story did not stop at the laboratory door. Her move into business development was not a departure from science. It was an expansion of it. The transition became possible because of her internal engagement, visibility, and willingness to step beyond defined responsibilities. In 2024–2025, she also served as an internal ambassador for Mabion, strengthening internal communication, supporting company initiatives, and representing the organization from within. That role reflected trust and investment.
Today, as a Business Development Specialist at Mabion Biologics CDMO, she bridges technical understanding with strategic partnership. She does not “sell services.” Klaudia translates science into opportunity. She understands clients because she understands the process behind their molecules.
In her PharmTech interview, Klaudia speaks about laboratory practice and academic education as a foundation for confidence. Yet her own path illustrates something even more powerful: women in biopharma are not confined to laboratory careers. With the right internal mobility and support, they can thrive in business, negotiations, and strategic growth without ever losing their scientific identity.
The Art of Precision: Natalia and the Architecture of Analytical Confidence
If Klaudia’s story is about movement across roles, Natalia Wojnowska’s is about depth.
In her interview for CPHI Online, Natalia opens the door to a world often invisible outside R&D. Natalia describes her work in biological analytical methods as solving a puzzle. Indeed, ligand-binding assays such as ELISA or SPR, which are her specialty, require high precision and certainty.2
With a background in genetics and experimental biology, Natalia’s early career spanned microbiology laboratories, bacteriophage research, and international academic internship. She learned to embrace uncertainty, to interpret unexpected outcomes not as failure but as information. That intellectual resilience now defines her role in Mabion’s R&D Department. Her work strengthens our analytical backbone.
One of her defining professional moments was presenting at the BEBPA 2024 European Bioassay Conference. She presented work on orthogonal techniques for dual-binding assessment using an AQbD approach. It was her first experience with bispecific antibodies so it required navigating unknown territory. She speaks openly about the challenges of that project, and equally openly about the support that carried her forward.
The female leaders she met at Mabion played a big role in her development. Paulina Toboła, Analytics Development Division Manager and Natalia’s immediate supervisor, represents a leadership style based on presence. She provides space for discussion rather than judgment, turning uncertainty into structured learning instead of pressure. Mistakes become material for growth, not reasons for hesitation. At the same time Edyta Bartusik-Czubek, Director of R&D Department, creates an environment where young specialists feel seen. Broader strategic support ensures that development is not random but deliberate.
That support illustrates something essential. Development is rarely solitary. Women in biopharma benefit from visible leadership and organized mentoring.3 Natalia’s story reflects the importance of a visible ladder of development. It shows how leadership creates continuity. From specialist to presenter. From analyst to expert voice in international forums. Analytical excellence is not born in isolation. It is cultivated in an environment where ambition is encouraged and expertise is recognized.
Her story shows that excellence in analytics does not emerge in isolation. It grows in an environment where leadership believes in potential and actively reinforces it.
A Culture That Builds Scientists
The stories of Klaudia and Natalia are not isolated narratives. They are reflections of a broader environment.
The trajectories of Klaudia and Natalia are distinct, yet interconnected. One moved outward from the lab into business strategy. The other moved deeper into analytical expertise and international scientific recognition. Both paths were enabled by an environment that values development over hierarchy and mobility over limitation.
At Mabion Biologics CDMO, scientific development is not treated as a static job description. Recruitment focuses not only on competence, but on potential – on the ability to contribute to international, cross-functional biologics projects that span development, analytics, manufacturing, and regulatory engagement. From early-career scientists to experienced specialists, the expectation is growth.
The company supports grassroots initiatives aimed at innovation, encouraging employees to refine methods, challenge assumptions, and contribute ideas that strengthen processes. Development is formalized through individual development plans, creating structured progression rather than leaving growth to chance. Importantly, this framework applies to all genders. Scientific excellence demands diversity of thought and equitable opportunity.4
Ultimately, the story of Mabion is not about celebrating women in biopharma for a single day. It is about creating an environment where talent can evolve without constraint. Whether at the bench, in analytics, or at the negotiation table.
If you would like to join us and develop your career at Mabion, check out the available positions in the Careers tab.
Prepared by:
Marketing Specialist
Sources
- Haigney S. Women in STEM: Unique Impacts in Rare Disease Development. PharmTech (Pharmaceutical Technology). 2026.
- Chard L. A Day in the Life of a Specialist in Biological Analytical Methods. CPHI Online. 2026.
- Deraniyagala A. Leadership Is Action, Not Position. The Nucleus. Association for Women in Science. 2025.
- UNESCO & Femmes Numérique. From Vision to Impact: Redefining STEM by Closing the Gender Gap. Conference. 2026.